0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prevent Meningitis Vaccine Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-39W12246
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Prevent Meningitis Vaccine Market Research Report 2022
BUY CHAPTERS

Global Prevent Meningitis Vaccine Market Research Report 2025

Code: QYRE-Auto-39W12246
Report
March 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Prevent Meningitis Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prevent Meningitis Vaccine Market

Prevent Meningitis Vaccine Market

The global market for Prevent Meningitis Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prevent Meningitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prevent Meningitis Vaccine.
The Prevent Meningitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prevent Meningitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prevent Meningitis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prevent Meningitis Vaccine Market Report

Report Metric Details
Report Name Prevent Meningitis Vaccine Market
CAGR 5%
Segment by Type
Segment by Application
  • Baby
  • Child
  • Teenager
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Pfizer, Merck, Novartis, Baxter International, Sanofi Pasteur, CSL Behring, JN International Medical Corporation, Serum Institute of India, Bio-Med, Hualan Bio, Wyeth Pharmaceuticals, Inc, Walvax, Zhejiang Tianyuan, Beijing Tiantan Biological, China National Biotec Group, Tianjin CanSino Biotechnology, Zhifei
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prevent Meningitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prevent Meningitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Prevent Meningitis Vaccine Market report?

Ans: The main players in the Prevent Meningitis Vaccine Market are GSK, Pfizer, Merck, Novartis, Baxter International, Sanofi Pasteur, CSL Behring, JN International Medical Corporation, Serum Institute of India, Bio-Med, Hualan Bio, Wyeth Pharmaceuticals, Inc, Walvax, Zhejiang Tianyuan, Beijing Tiantan Biological, China National Biotec Group, Tianjin CanSino Biotechnology, Zhifei

What are the Application segmentation covered in the Prevent Meningitis Vaccine Market report?

Ans: The Applications covered in the Prevent Meningitis Vaccine Market report are Baby, Child, Teenager, Others

What are the Type segmentation covered in the Prevent Meningitis Vaccine Market report?

Ans: The Types covered in the Prevent Meningitis Vaccine Market report are Meningococcal A Vaccine, Meningococcal AC Vaccine, Meningococcal B Vaccine (MenB), Meningococcal Conjugate Vaccine (MenaCWY)

Recommended Reports

Bacterial Vaccines

Vaccine Equipment

Influenza Vaccines

1 Prevent Meningitis Vaccine Market Overview
1.1 Product Definition
1.2 Prevent Meningitis Vaccine by Type
1.2.1 Global Prevent Meningitis Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Meningococcal A Vaccine
1.2.3 Meningococcal AC Vaccine
1.2.4 Meningococcal B Vaccine (MenB)
1.2.5 Meningococcal Conjugate Vaccine (MenaCWY)
1.3 Prevent Meningitis Vaccine by Application
1.3.1 Global Prevent Meningitis Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Baby
1.3.3 Child
1.3.4 Teenager
1.3.5 Others
1.4 Global Prevent Meningitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Prevent Meningitis Vaccine Revenue 2020-2031
1.4.2 Global Prevent Meningitis Vaccine Sales 2020-2031
1.4.3 Global Prevent Meningitis Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prevent Meningitis Vaccine Market Competition by Manufacturers
2.1 Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prevent Meningitis Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prevent Meningitis Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prevent Meningitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prevent Meningitis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prevent Meningitis Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Prevent Meningitis Vaccine, Date of Enter into This Industry
2.8 Global Prevent Meningitis Vaccine Market Competitive Situation and Trends
2.8.1 Global Prevent Meningitis Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prevent Meningitis Vaccine Players Market Share by Revenue
2.8.3 Global Prevent Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prevent Meningitis Vaccine Market Scenario by Region
3.1 Global Prevent Meningitis Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prevent Meningitis Vaccine Sales by Region: 2020-2031
3.2.1 Global Prevent Meningitis Vaccine Sales by Region: 2020-2025
3.2.2 Global Prevent Meningitis Vaccine Sales by Region: 2026-2031
3.3 Global Prevent Meningitis Vaccine Revenue by Region: 2020-2031
3.3.1 Global Prevent Meningitis Vaccine Revenue by Region: 2020-2025
3.3.2 Global Prevent Meningitis Vaccine Revenue by Region: 2026-2031
3.4 North America Prevent Meningitis Vaccine Market Facts & Figures by Country
3.4.1 North America Prevent Meningitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prevent Meningitis Vaccine Sales by Country (2020-2031)
3.4.3 North America Prevent Meningitis Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prevent Meningitis Vaccine Market Facts & Figures by Country
3.5.1 Europe Prevent Meningitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prevent Meningitis Vaccine Sales by Country (2020-2031)
3.5.3 Europe Prevent Meningitis Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prevent Meningitis Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Prevent Meningitis Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prevent Meningitis Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Prevent Meningitis Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prevent Meningitis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Prevent Meningitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prevent Meningitis Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Prevent Meningitis Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prevent Meningitis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Prevent Meningitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prevent Meningitis Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prevent Meningitis Vaccine Sales by Type (2020-2031)
4.1.1 Global Prevent Meningitis Vaccine Sales by Type (2020-2025)
4.1.2 Global Prevent Meningitis Vaccine Sales by Type (2026-2031)
4.1.3 Global Prevent Meningitis Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Prevent Meningitis Vaccine Revenue by Type (2020-2031)
4.2.1 Global Prevent Meningitis Vaccine Revenue by Type (2020-2025)
4.2.2 Global Prevent Meningitis Vaccine Revenue by Type (2026-2031)
4.2.3 Global Prevent Meningitis Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Prevent Meningitis Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prevent Meningitis Vaccine Sales by Application (2020-2031)
5.1.1 Global Prevent Meningitis Vaccine Sales by Application (2020-2025)
5.1.2 Global Prevent Meningitis Vaccine Sales by Application (2026-2031)
5.1.3 Global Prevent Meningitis Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Prevent Meningitis Vaccine Revenue by Application (2020-2031)
5.2.1 Global Prevent Meningitis Vaccine Revenue by Application (2020-2025)
5.2.2 Global Prevent Meningitis Vaccine Revenue by Application (2026-2031)
5.2.3 Global Prevent Meningitis Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Prevent Meningitis Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Prevent Meningitis Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Prevent Meningitis Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Prevent Meningitis Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Prevent Meningitis Vaccine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Baxter International
6.5.1 Baxter International Company Information
6.5.2 Baxter International Description and Business Overview
6.5.3 Baxter International Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Baxter International Prevent Meningitis Vaccine Product Portfolio
6.5.5 Baxter International Recent Developments/Updates
6.6 Sanofi Pasteur
6.6.1 Sanofi Pasteur Company Information
6.6.2 Sanofi Pasteur Description and Business Overview
6.6.3 Sanofi Pasteur Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio
6.6.5 Sanofi Pasteur Recent Developments/Updates
6.7 CSL Behring
6.7.1 CSL Behring Company Information
6.7.2 CSL Behring Description and Business Overview
6.7.3 CSL Behring Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CSL Behring Prevent Meningitis Vaccine Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 JN International Medical Corporation
6.8.1 JN International Medical Corporation Company Information
6.8.2 JN International Medical Corporation Description and Business Overview
6.8.3 JN International Medical Corporation Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio
6.8.5 JN International Medical Corporation Recent Developments/Updates
6.9 Serum Institute of India
6.9.1 Serum Institute of India Company Information
6.9.2 Serum Institute of India Description and Business Overview
6.9.3 Serum Institute of India Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Serum Institute of India Prevent Meningitis Vaccine Product Portfolio
6.9.5 Serum Institute of India Recent Developments/Updates
6.10 Bio-Med
6.10.1 Bio-Med Company Information
6.10.2 Bio-Med Description and Business Overview
6.10.3 Bio-Med Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bio-Med Prevent Meningitis Vaccine Product Portfolio
6.10.5 Bio-Med Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Company Information
6.11.2 Hualan Bio Description and Business Overview
6.11.3 Hualan Bio Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hualan Bio Prevent Meningitis Vaccine Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 Wyeth Pharmaceuticals, Inc
6.12.1 Wyeth Pharmaceuticals, Inc Company Information
6.12.2 Wyeth Pharmaceuticals, Inc Description and Business Overview
6.12.3 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio
6.12.5 Wyeth Pharmaceuticals, Inc Recent Developments/Updates
6.13 Walvax
6.13.1 Walvax Company Information
6.13.2 Walvax Description and Business Overview
6.13.3 Walvax Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Walvax Prevent Meningitis Vaccine Product Portfolio
6.13.5 Walvax Recent Developments/Updates
6.14 Zhejiang Tianyuan
6.14.1 Zhejiang Tianyuan Company Information
6.14.2 Zhejiang Tianyuan Description and Business Overview
6.14.3 Zhejiang Tianyuan Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio
6.14.5 Zhejiang Tianyuan Recent Developments/Updates
6.15 Beijing Tiantan Biological
6.15.1 Beijing Tiantan Biological Company Information
6.15.2 Beijing Tiantan Biological Description and Business Overview
6.15.3 Beijing Tiantan Biological Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio
6.15.5 Beijing Tiantan Biological Recent Developments/Updates
6.16 China National Biotec Group
6.16.1 China National Biotec Group Company Information
6.16.2 China National Biotec Group Description and Business Overview
6.16.3 China National Biotec Group Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 China National Biotec Group Prevent Meningitis Vaccine Product Portfolio
6.16.5 China National Biotec Group Recent Developments/Updates
6.17 Tianjin CanSino Biotechnology
6.17.1 Tianjin CanSino Biotechnology Company Information
6.17.2 Tianjin CanSino Biotechnology Description and Business Overview
6.17.3 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio
6.17.5 Tianjin CanSino Biotechnology Recent Developments/Updates
6.18 Zhifei
6.18.1 Zhifei Company Information
6.18.2 Zhifei Description and Business Overview
6.18.3 Zhifei Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Zhifei Prevent Meningitis Vaccine Product Portfolio
6.18.5 Zhifei Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prevent Meningitis Vaccine Industry Chain Analysis
7.2 Prevent Meningitis Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prevent Meningitis Vaccine Production Mode & Process Analysis
7.4 Prevent Meningitis Vaccine Sales and Marketing
7.4.1 Prevent Meningitis Vaccine Sales Channels
7.4.2 Prevent Meningitis Vaccine Distributors
7.5 Prevent Meningitis Vaccine Customer Analysis
8 Prevent Meningitis Vaccine Market Dynamics
8.1 Prevent Meningitis Vaccine Industry Trends
8.2 Prevent Meningitis Vaccine Market Drivers
8.3 Prevent Meningitis Vaccine Market Challenges
8.4 Prevent Meningitis Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Prevent Meningitis Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prevent Meningitis Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prevent Meningitis Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prevent Meningitis Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prevent Meningitis Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prevent Meningitis Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prevent Meningitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prevent Meningitis Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prevent Meningitis Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Prevent Meningitis Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prevent Meningitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prevent Meningitis Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prevent Meningitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prevent Meningitis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Prevent Meningitis Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Prevent Meningitis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Prevent Meningitis Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Prevent Meningitis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Prevent Meningitis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Prevent Meningitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prevent Meningitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Prevent Meningitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Prevent Meningitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prevent Meningitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prevent Meningitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prevent Meningitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Prevent Meningitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Prevent Meningitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prevent Meningitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prevent Meningitis Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prevent Meningitis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Prevent Meningitis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Prevent Meningitis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prevent Meningitis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prevent Meningitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prevent Meningitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Prevent Meningitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Prevent Meningitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prevent Meningitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prevent Meningitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Prevent Meningitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prevent Meningitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prevent Meningitis Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Prevent Meningitis Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Prevent Meningitis Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Prevent Meningitis Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Prevent Meningitis Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Prevent Meningitis Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Prevent Meningitis Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Prevent Meningitis Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Prevent Meningitis Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Prevent Meningitis Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Prevent Meningitis Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Prevent Meningitis Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GSK Prevent Meningitis Vaccine Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Prevent Meningitis Vaccine Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Prevent Meningitis Vaccine Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Prevent Meningitis Vaccine Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Baxter International Company Information
 Table 91. Baxter International Description and Business Overview
 Table 92. Baxter International Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Baxter International Prevent Meningitis Vaccine Product
 Table 94. Baxter International Recent Developments/Updates
 Table 95. Sanofi Pasteur Company Information
 Table 96. Sanofi Pasteur Description and Business Overview
 Table 97. Sanofi Pasteur Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sanofi Pasteur Prevent Meningitis Vaccine Product
 Table 99. Sanofi Pasteur Recent Developments/Updates
 Table 100. CSL Behring Company Information
 Table 101. CSL Behring Description and Business Overview
 Table 102. CSL Behring Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CSL Behring Prevent Meningitis Vaccine Product
 Table 104. CSL Behring Recent Developments/Updates
 Table 105. JN International Medical Corporation Company Information
 Table 106. JN International Medical Corporation Description and Business Overview
 Table 107. JN International Medical Corporation Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. JN International Medical Corporation Prevent Meningitis Vaccine Product
 Table 109. JN International Medical Corporation Recent Developments/Updates
 Table 110. Serum Institute of India Company Information
 Table 111. Serum Institute of India Description and Business Overview
 Table 112. Serum Institute of India Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Serum Institute of India Prevent Meningitis Vaccine Product
 Table 114. Serum Institute of India Recent Developments/Updates
 Table 115. Bio-Med Company Information
 Table 116. Bio-Med Description and Business Overview
 Table 117. Bio-Med Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Bio-Med Prevent Meningitis Vaccine Product
 Table 119. Bio-Med Recent Developments/Updates
 Table 120. Hualan Bio Company Information
 Table 121. Hualan Bio Description and Business Overview
 Table 122. Hualan Bio Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hualan Bio Prevent Meningitis Vaccine Product
 Table 124. Hualan Bio Recent Developments/Updates
 Table 125. Wyeth Pharmaceuticals, Inc Company Information
 Table 126. Wyeth Pharmaceuticals, Inc Description and Business Overview
 Table 127. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product
 Table 129. Wyeth Pharmaceuticals, Inc Recent Developments/Updates
 Table 130. Walvax Company Information
 Table 131. Walvax Description and Business Overview
 Table 132. Walvax Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Walvax Prevent Meningitis Vaccine Product
 Table 134. Walvax Recent Developments/Updates
 Table 135. Zhejiang Tianyuan Company Information
 Table 136. Zhejiang Tianyuan Description and Business Overview
 Table 137. Zhejiang Tianyuan Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Zhejiang Tianyuan Prevent Meningitis Vaccine Product
 Table 139. Zhejiang Tianyuan Recent Developments/Updates
 Table 140. Beijing Tiantan Biological Company Information
 Table 141. Beijing Tiantan Biological Description and Business Overview
 Table 142. Beijing Tiantan Biological Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Beijing Tiantan Biological Prevent Meningitis Vaccine Product
 Table 144. Beijing Tiantan Biological Recent Developments/Updates
 Table 145. China National Biotec Group Company Information
 Table 146. China National Biotec Group Description and Business Overview
 Table 147. China National Biotec Group Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. China National Biotec Group Prevent Meningitis Vaccine Product
 Table 149. China National Biotec Group Recent Developments/Updates
 Table 150. Tianjin CanSino Biotechnology Company Information
 Table 151. Tianjin CanSino Biotechnology Description and Business Overview
 Table 152. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product
 Table 154. Tianjin CanSino Biotechnology Recent Developments/Updates
 Table 155. Zhifei Company Information
 Table 156. Zhifei Description and Business Overview
 Table 157. Zhifei Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Zhifei Prevent Meningitis Vaccine Product
 Table 159. Zhifei Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Prevent Meningitis Vaccine Distributors List
 Table 163. Prevent Meningitis Vaccine Customers List
 Table 164. Prevent Meningitis Vaccine Market Trends
 Table 165. Prevent Meningitis Vaccine Market Drivers
 Table 166. Prevent Meningitis Vaccine Market Challenges
 Table 167. Prevent Meningitis Vaccine Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prevent Meningitis Vaccine
 Figure 2. Global Prevent Meningitis Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prevent Meningitis Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Meningococcal A Vaccine Product Picture
 Figure 5. Meningococcal AC Vaccine Product Picture
 Figure 6. Meningococcal B Vaccine (MenB) Product Picture
 Figure 7. Meningococcal Conjugate Vaccine (MenaCWY) Product Picture
 Figure 8. Global Prevent Meningitis Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Prevent Meningitis Vaccine Market Share by Application: 2024 & 2031
 Figure 10. Baby
 Figure 11. Child
 Figure 12. Teenager
 Figure 13. Others
 Figure 14. Global Prevent Meningitis Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Prevent Meningitis Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Prevent Meningitis Vaccine Sales (2020-2031) & (K Units)
 Figure 17. Global Prevent Meningitis Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 18. Prevent Meningitis Vaccine Report Years Considered
 Figure 19. Prevent Meningitis Vaccine Sales Share by Manufacturers in 2024
 Figure 20. Global Prevent Meningitis Vaccine Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Prevent Meningitis Vaccine Players: Market Share by Revenue in Prevent Meningitis Vaccine in 2024
 Figure 22. Prevent Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Prevent Meningitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Prevent Meningitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. North America Prevent Meningitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. United States Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Prevent Meningitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 29. Europe Prevent Meningitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Prevent Meningitis Vaccine Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Prevent Meningitis Vaccine Revenue Market Share by Region (2020-2031)
 Figure 37. China Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Prevent Meningitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Prevent Meningitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Prevent Meningitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Prevent Meningitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Prevent Meningitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Prevent Meningitis Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Prevent Meningitis Vaccine by Type (2020-2031)
 Figure 56. Global Prevent Meningitis Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Prevent Meningitis Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Prevent Meningitis Vaccine by Application (2020-2031)
 Figure 59. Global Prevent Meningitis Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Prevent Meningitis Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI